- Home
- GNFT vs IHRT Comparison
GNFT vs IHRT Comparison
Compare GNFT & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- IHRT
- Stock Information
- Founded
- GNFT 1999
- IHRT N/A
- Country
- GNFT France
- IHRT United States
- Employees
- GNFT N/A
- IHRT N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- IHRT Broadcasting
- Sector
- GNFT Health Care
- IHRT Consumer Discretionary
- Exchange
- GNFT Nasdaq
- IHRT Nasdaq
- Market Cap
- GNFT 296.4M
- IHRT 296.6M
- IPO Year
- GNFT 2019
- IHRT 2019
- Fundamental
- Price
- GNFT $3.82
- IHRT $2.29
- Analyst Decision
- GNFT Strong Buy
- IHRT Buy
- Analyst Count
- GNFT 1
- IHRT 3
- Target Price
- GNFT $13.00
- IHRT $3.00
- AVG Volume (30 Days)
- GNFT 6.7K
- IHRT 896.8K
- Earning Date
- GNFT 09-19-2024
- IHRT 11-07-2024
- Dividend Yield
- GNFT N/A
- IHRT N/A
- EPS Growth
- GNFT N/A
- IHRT N/A
- EPS
- GNFT 0.47
- IHRT N/A
- Revenue
- GNFT $86,225,222.00
- IHRT $3,803,046,000.00
- Revenue This Year
- GNFT $155.44
- IHRT $6.16
- Revenue Next Year
- GNFT N/A
- IHRT N/A
- P/E Ratio
- GNFT $7.73
- IHRT N/A
- Revenue Growth
- GNFT 175.45
- IHRT N/A
- 52 Week Low
- GNFT $3.31
- IHRT $0.81
- 52 Week High
- GNFT $6.42
- IHRT $3.04
- Technical
- Relative Strength Index (RSI)
- GNFT 26.50
- IHRT 49.14
- Support Level
- GNFT $3.73
- IHRT $2.26
- Resistance Level
- GNFT $4.06
- IHRT $2.71
- Average True Range (ATR)
- GNFT 0.12
- IHRT 0.18
- MACD
- GNFT 0.01
- IHRT -0.02
- Stochastic Oscillator
- GNFT 12.49
- IHRT 19.23
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About IHRT iHeartMedia Inc.
iHeartMedia Inc is a United States-based diversified media and entertainment company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.